Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence.

Suh JJ, Pettinati HM, Kampman KM, O'Brien CP.

Am J Addict. 2008 Nov-Dec;17(6):463-8. doi: 10.1080/10550490802409074.

2.

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Suh JJ, Dackis CA, Oslin DW, O'Brien CP.

J Subst Abuse Treat. 2008 Jun;34(4):378-90. Epub 2007 Jul 30.

3.

A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Xie H, Dackis C, Rabinowitz AR, O'Brien CP.

Addict Behav. 2008 May;33(5):651-67. Epub 2007 Nov 17.

4.

Effects of naltrexone on cue-elicited craving for alcohol and cocaine.

Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR.

Drug Alcohol Depend. 1997 Dec;49(1):9-16.

PMID:
9476694
5.

Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Greenfield SF, Pettinati HM, O'Malley S, Randall PK, Randall CL.

Alcohol Clin Exp Res. 2010 Oct;34(10):1803-12. doi: 10.1111/j.1530-0277.2010.01267.x. Epub 2010 Jul 20.

6.

The effects of naltrexone on alcohol and cocaine use in dually addicted patients.

Oslin DW, Pettinati HM, Volpicelli JR, Wolf AL, Kampman KM, O'Brien CP.

J Subst Abuse Treat. 1999 Mar;16(2):163-7.

PMID:
10023615
7.

Naltrexone treatment of comorbid alcohol and cocaine use disorders.

Hersh D, Van Kirk JR, Kranzler HR.

Psychopharmacology (Berl). 1998 Sep;139(1-2):44-52.

PMID:
9768541
8.

High-Dose Naltrexone Treatment and Gender in Alcohol Dependence.

Yoon G, Kim SW, Petrakis IL, Westermeyer J.

Clin Neuropharmacol. 2016 Jul-Aug;39(4):165-8. doi: 10.1097/WNF.0000000000000152.

PMID:
27046656
9.

High-dose naltrexone therapy for cocaine-alcohol dependence.

Schmitz JM, Lindsay JA, Green CE, Herin DV, Stotts AL, Moeller FG.

Am J Addict. 2009 Sep-Oct;18(5):356-62. doi: 10.3109/10550490903077929.

10.

A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Dundon WD, Mahoney EM, Wierzbicki MR, O'Brien CP.

Am J Addict. 2014 Nov-Dec;23(6):591-7. doi: 10.1111/j.1521-0391.2014.12146.x. Epub 2014 Sep 22.

PMID:
25251201
11.

Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone.

Vuoristo-Myllys S, Lahti J, Alho H, Julkunen J.

J Stud Alcohol Drugs. 2013 Nov;74(6):894-901.

PMID:
24172116
12.

Naltrexone in the treatment of alcoholism: a clinical review.

O'Brien CP, Volpicelli LA, Volpicelli JR.

Alcohol. 1996 Jan-Feb;13(1):35-9. Review.

PMID:
8837932
13.

Naltrexone and disulfiram in patients with alcohol dependence and current depression.

Petrakis I, Ralevski E, Nich C, Levinson C, Carroll K, Poling J, Rounsaville B; VA VISN I MIRECC Study Group.

J Clin Psychopharmacol. 2007 Apr;27(2):160-5.

PMID:
17414239
14.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
15.

Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.

Schmitz JM, Stotts AL, Sayre SL, DeLaune KA, Grabowski J.

Am J Addict. 2004 Jul-Sep;13(4):333-41.

PMID:
15370932
16.

A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment.

Kiefer F, Jahn H, Wiedemann K.

Pharmacopsychiatry. 2005 Jul;38(4):184-6.

PMID:
16025425
17.

Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.

Ahmadi J, Kampman KM, Oslin DM, Pettinati HM, Dackis C, Sparkman T.

Am J Addict. 2009 Jan-Feb;18(1):81-6. doi: 10.1080/10550490802545174.

18.

Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?

Baros AM, Latham PK, Anton RF.

Alcohol Clin Exp Res. 2008 May;32(5):771-6. doi: 10.1111/j.1530-0277.2008.00633.x. Epub 2008 Mar 11.

19.

[Efficacy of naltrexone in the treatment of alcohol dependence disorder in women].

Ponce G, Sánchez-García J, Rubio G, Rodríguez-Jiménez R, Jiménez-Arriero MA, Palomo T.

Actas Esp Psiquiatr. 2005 Jan-Feb;33(1):13-8. Spanish.

PMID:
15704026
20.

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group.

JAMA. 2005 Apr 6;293(13):1617-25. Erratum in: JAMA. 2005 Apr 27;293(16):1978. JAMA. 2005 Jun 15:293(23):2864.

PMID:
15811981

Supplemental Content

Support Center